Subgroup analyses revealed important differences based on comparator drugs: GLP-1RAs demonstrated greater effectiveness than SGLT2 inhibitors in preventing MALOs (IRR: 0.93, 95%CI: 0.87-0.99, P = 0.043), than DPP-4 inhibitors in preventing hepatic decompensation events (IRR: 0.74, 95%CI: 0.66-0.83, P = 0.003), and than insulin therapy in averting HCC development (IRR: 0.32, 95%CI: 0.13-0.80, P = 0.033) [64]
We suggest that these data may form the basis of improving therapeutic strategies for the treatment of antihormone resistant ER-positive breast cancer
Coyne KS, Currie BM, Thompson CL et al: The test-retest reliability of the Peyronie's Disease Questionnaire
Patients often seek out compounded versions of the medications because the brand-name versions are expensive, she said
If you don't eat enough of the right foods, for example, you may not consume enough of the amino acids needed to synthesize glutathione